Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder 2017

Hulayel Alharbi; Sultan Alkhateeb; Esam Murshid; Mohammed Alotaibi; Ashraf Abusamra; Danny Rabah; Mubarak Almansour; Abdullah Alghamdi; Ali Aljubran; Amin Eltigani; Hussein Alkushi; Imran Ahmed; Abdullah Alsharm; Shouki Bazarbashi

doi:10.4103/UA.UA_176_17

Page layout

Editorial Board | Subscribe | Advertise | Contact

Users Online: 2240

REVIEW ARTICLE

Year : 2018 | Volume : 10 | Issue : 2 | Page : 133-137

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder 2017

Hulayel Alharbi¹, Sultan Alkhateeb², Esam Murshid³, Mohammed Alotaibi⁴, Ashraf Abusamra⁵, Danny Rabah⁶, Mubarak Almansour⁷, Abdullah Alghamdi⁸, Ali Aljubran⁹, Amin Eltigani¹⁰, Hussein Alkushi¹¹, Imran Ahmed¹², Abdullah Alsharm¹³, Shouki Bazarbashi⁹
¹ Department of Medical Oncology, King Fahed Specialist Hospital, Dammam, Saudi Arabia
² Department of Surgery, Division of Urology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
³ Department of Oncology, Oncology Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
⁴ Department of Urology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
⁵ Department of Surgery, Urology Section, King Khalid Hospital, King Abdulaziz Medical City, Jeddah, Saudi Arabia
⁶ Department of Surgery, College of Medicine and Uro-Oncology Research Chair, King Saud University, Riyadh, Saudi Arabia
⁷ Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
⁸ Department of Urology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
⁹ Oncology Center, Section of Medical Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
¹⁰ Department of Oncology, Division of Medical Oncology, King Abdulaziz Medical City and King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
¹¹ Department of Pathology, King Abdulaziz Medical City and King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
¹² Department of Oncology, Section of Medical Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
¹³ Department of Medical Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia

Correspondence Address:
Dr. Shouki Bazarbashi
Section of Medical Oncology, Oncology Center, King Faisal Specialist Hospital and Research Center, P.O Box 3354, Riyadh 11211
Saudi Arabia

Check

DOI: 10.4103/UA.UA_176_17

PMID: 29719322

This is an update to the previously published Saudi guidelines for the evaluation and medical/surgical management of patients diagnosed with urothelial cell carcinoma of the urinary bladder. It is categorized according to the stage of the disease using the tumor node metastasis staging system, 7^th edition. The guidelines are presented with their accompanying supporting evidence level, which is based on comprehensive literature review, several internationally recognized guidelines, and the collective expertise of the guidelines committee members (authors) who were selected by the Saudi Oncology Society and Saudi Urological Association. Considerations to the local availability of drugs, technology, and expertise have been regarded. These guidelines should serve as a roadmap for the urologists, oncologists, general physicians, support groups, and health-care policymakers in the management of patients diagnosed with urothelial cell carcinoma of the urinary bladder.

[FULL TEXT] [PDF]*

Table of Contents

Similar in PUBMED

Search Pubmed for

Search in Google Scholar for

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	3172

Printed	72

Emailed	0

PDF Downloaded	344

Comments	[Add]